Orphan Drugs: Latest Regulatory, Compliance and Legal Developments | McDermott

Orphan Drugs: Latest Regulatory, Compliance and Legal Developments

Overview


Brian Malkin joins WCG for their event, “Orphan Drugs: Latest Regulatory, Compliance and Legal Developments.” Brian will discuss “perspectives from a cross-section of current and former FDA regulators, FDA litigators and major orphan drug trade organizations.”

Learn more and register here.